Skip to main content
Premium Trial:

Request an Annual Quote

Epigenomics: Greg Hamilton

Epigenomics announced the resignation of Greg Hamilton as CEO and as a member of the firm's executive board, effective June 30. He has been the company's CEO since July 2016. The German cancer diagnostics firm said the changes are in connection with its recent revised strategy. In February, Epigenomics announced a restructuring, including the recall of its Epi proColon test for colorectal cancer, staff cuts, and a reduction of its remaining operations. The company also said it will have discussions with its executive board about the future composition of the executive board. 

The Scan

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.

Sequencing Analysis Examines Gene Regulatory Networks of Honeybee Soldier, Forager Brains

Researchers in Nature Ecology & Evolution find gene regulatory network differences between soldiers and foragers, suggesting bees can take on either role.

Analysis of Ashkenazi Jewish Cohort Uncovers New Genetic Loci Linked to Alzheimer's Disease

The study in Alzheimer's & Dementia highlighted known genes, but also novel ones with biological ties to Alzheimer's disease.

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.